KIT and neoplasm: We observed that mice bearing triple-negative SUM159 tumors had a significantly higher percentage of CD117+ cells in their bone marrow relative to mice bearing luminal A MCF7 tumors or tumor-naïve, age-matched control mice (p ≤ 0.05) (Figure 1).